Literature DB >> 8803988

Clinical assessment of dry weight.

B Charra1, G Laurent, C Chazot, E Calemard, J C Terrat, T Vanel, G Jean, M Ruffet.   

Abstract

Unsatisfactory control of blood pressure (BP) leading to an increased rate of cardiovascular events is the main cause of mortality in haemodialysis. BP control has deteriorated since haemodialysis session times have been reduced. Inadequate BP control most often is due to a failure to achieve and maintain dry weight. Dry weight and normotension have been gradually omitted in the goals of dialysis, satisfactory dialysis being reduced to an 'adequate' urea Kt/V. Ideal dry body weight needs a reappraisal. What is dry weight? How should it be clinically assessed, established and maintained in patients? The problems encountered in estimating dry weight can be solved at the bedside in most cases. The additional laboratory, echography and impedancemetry methods are research tools that hopefully can be made simpler and lower in cost so they can be used everyday at the bedside. In the mean time, with the exception of ambulatory blood pressure measurement, one must rely on careful and repeated clinical observation to determine and maintain dry weight.

Entities:  

Mesh:

Year:  1996        PMID: 8803988     DOI: 10.1093/ndt/11.supp2.16

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  37 in total

Review 1.  Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.

Authors:  Rajiv Agarwal; Matthew R Weir
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

2.  Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients.

Authors:  Charles Chazot; Margaux Rozes; Cyril Vo-Van; Patrik Deleaval; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Eric Zaoui; Guillaume Jean
Journal:  Cardiorenal Med       Date:  2017-04-29       Impact factor: 2.041

Review 3.  Setting the dry weight and its cardiovascular implications.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

Review 4.  Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient.

Authors:  Jason A Chou; Kamyar Kalantar-Zadeh
Journal:  Curr Heart Fail Rep       Date:  2017-10

Review 5.  High blood pressure in dialysis patients: cause, pathophysiology, influence on morbidity, mortality and management.

Authors:  Aaron Stern; Soumya Sachdeva; Rohit Kapoor; Jasjit Singh; Sarthak Sachdeva
Journal:  J Clin Diagn Res       Date:  2014-06-20

6.  The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.

Authors:  Luminita Voroneanu; Claudiu Cusai; Simona Hogas; Serban Ardeleanu; Mihai Onofriescu; Ionut Nistor; Octavian Prisada; Radu Sascau; David Goldsmith; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2010-06-04       Impact factor: 2.370

7.  Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Deborah L Regidor; Csaba P Kovesdy; David Van Wyck; Suphamai Bunnapradist; Tamara B Horwich; Gregg C Fonarow
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

8.  Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring.

Authors:  Rajiv Agarwal; Robert P Light
Journal:  Am J Kidney Dis       Date:  2009-06-10       Impact factor: 8.860

9.  B-type natriuretic peptide is not a volume marker among patients on hemodialysis.

Authors:  Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-03-22       Impact factor: 5.992

10.  Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure.

Authors:  Teena Tandon; Arjun D Sinha; Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-01-24       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.